{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:45:17Z","timestamp":1791002717632,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Detection of <jats:italic>BRAF<\/jats:italic><jats:sup>V600E<\/jats:sup> within cell free tumor DNA (ctDNA) is emerging as a promising means to improve patients\u2019 stratification or enable BRAF inhibitor (BRAFi) therapeutic monitoring in a minimally invasive manner. Here, we investigated whether extracellular vesicle-(EV)-associated-DNA (EV-DNA) has value as an alternative source of circulating <jats:italic>BRAF<\/jats:italic><jats:sup>V600E<\/jats:sup>. To do so, we identified a clinical practice-compatible protocol for the isolation of EV-DNA and assessed <jats:italic>BRAF<\/jats:italic> gene status on plasma samples from metastatic melanoma patients at the beginning and during BRAFi therapy. This protocol uses a peptide with high affinity for EVs and it has been found to recover more mutant DNA from plasma than standard ultracentrifugation. Molecular analyses revealed that mutant DNA is largely unprotected from nuclease digestion, interacting with the outer side of the EV membrane or directly with the peptide. When used on clinical samples, we found that the protocol improves the detection of <jats:italic>BRAF<\/jats:italic><jats:sup>V600E<\/jats:sup> gene copies in comparison to the reference protocol for ctDNA isolation. Taken together, these findings indicate that EVs are a promising source of mutant DNA and should be considered for the development of next-generation liquid biopsy approaches.\n<\/jats:p>","DOI":"10.1038\/s41598-020-72834-6","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T10:02:43Z","timestamp":1601028163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients"],"prefix":"10.1038","volume":"10","author":[{"given":"Davide","family":"Zocco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3494-2624","authenticated-orcid":false,"given":"Simona","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Astrua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Zarovni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco M.","family":"Carpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bianciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavia","family":"Malavenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Quaglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Foroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Chiesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Fierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"72834_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949\u2013954 (2002).","journal-title":"Nature"},{"key":"72834_CR2","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty, K. T. et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N. Engl. J. Med. 367, 1694\u20131703 (2012).","journal-title":"N. Engl. J. Med."},{"key":"72834_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1056\/NEJMoa1112302","volume":"366","author":"JA Sosman","year":"2012","unstructured":"Sosman, J. A. et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N. Engl. J. Med. 366, 707\u2013714 (2012).","journal-title":"N. Engl. J. Med."},{"key":"72834_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejca.2017.05.015","volume":"81","author":"A Valachis","year":"2017","unstructured":"Valachis, A. & Ullenhag, G. J. Discrepancy in BRAF status among patients with metastatic malignant melanoma: a meta-analysis. Eur. J. Cancer 81, 106\u2013115 (2017).","journal-title":"Eur. J. Cancer"},{"key":"72834_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","volume":"32","author":"LA Diaz Jr","year":"2014","unstructured":"Diaz, L. A. Jr. & Bardelli, A. Liquid biopsies: genotyping circulating tumor DNA. J. Clin. Oncol. 32, 579\u2013586 (2014).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"72834_CR6","doi-asserted-by":"publisher","first-page":"029587","DOI":"10.1101\/cshperspect.a029587","volume":"7","author":"M Russo","year":"2017","unstructured":"Russo, M. & Bardelli, A. Lesion-directed therapies and monitoring tumor evolution using liquid biopsies. Cold Spring Harb. Perspect. Med. 7(2), 029587 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"6","key":"72834_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CMR.0000000000000187","volume":"25","author":"M Gonzalez-Cao","year":"2015","unstructured":"Gonzalez-Cao, M. et al. BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors. Melanoma Res. 25(6), 486\u2013495 (2015).","journal-title":"Melanoma Res."},{"issue":"1","key":"72834_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1373\/clinchem.2014.230235","volume":"61","author":"MF Sanmamed","year":"2015","unstructured":"Sanmamed, M. F. et al. Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors. Clin Chem. 61(1), 297\u2013304 (2015).","journal-title":"Clin Chem."},{"issue":"2","key":"72834_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1039\/C5AN01762A","volume":"141","author":"KA Hyun","year":"2016","unstructured":"Hyun, K. A., Kim, J., Gwak, H. & Jung, H. I. Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics. Analyst 141(2), 382\u2013392 (2016).","journal-title":"Analyst"},{"issue":"4","key":"72834_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 200(4), 373\u2013383 (2013).","journal-title":"J Cell Biol."},{"key":"72834_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo, M., Raposo, G. & Th\u00e9ry, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255\u2013289 (2014).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"1","key":"72834_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/CCO.0b013e32835b7c81","volume":"25","author":"VR Martins","year":"2013","unstructured":"Martins, V. R., Dias, M. S. & Hainaut, P. Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr. Opin. Oncol. 25(1), 66\u201375 (2013).","journal-title":"Curr. Opin. Oncol."},{"issue":"6","key":"72834_CR13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker, A. et al. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 30(6), 836\u2013848 (2016).","journal-title":"Cancer Cell"},{"issue":"7578","key":"72834_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527(7578), 329\u2013335 (2015).","journal-title":"Nature"},{"issue":"6","key":"72834_CR15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18(6), 883\u2013891 (2012).","journal-title":"Nat. Med."},{"issue":"4","key":"72834_CR16","doi-asserted-by":"publisher","first-page":"e5219","DOI":"10.1371\/journal.pone.0005219","volume":"4","author":"M Logozzi","year":"2009","unstructured":"Logozzi, M. et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 4(4), e5219 (2009).","journal-title":"PLoS ONE"},{"issue":"6","key":"72834_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9(6), 654\u2013659 (2007).","journal-title":"Nat. Cell Biol."},{"key":"72834_CR18","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"12","author":"J Skog","year":"2008","unstructured":"Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 12, 1470\u20131476 (2008).","journal-title":"Nat. Cell Biol."},{"key":"72834_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ncomms1180","volume":"2","author":"L Balaj","year":"2011","unstructured":"Balaj, L. et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat. Commun. 2, 180 (2011).","journal-title":"Nat. Commun."},{"issue":"7","key":"72834_CR20","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1074\/jbc.C113.532267","volume":"289","author":"C Kahlert","year":"2014","unstructured":"Kahlert, C. et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J. Biol. Chem. 289(7), 3869\u20133875 (2014).","journal-title":"J. Biol. Chem."},{"issue":"6","key":"72834_CR21","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/cr.2014.44","volume":"24","author":"BK Thakur","year":"2014","unstructured":"Thakur, B. K. et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 24(6), 766\u2013769 (2014).","journal-title":"Cell Res."},{"key":"72834_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/annonc\/mdx004","volume":"28","author":"K Allenson","year":"2017","unstructured":"Allenson, K. et al. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Ann. Oncol. 28, 741\u2013747 (2017).","journal-title":"Ann. Oncol."},{"key":"72834_CR23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/0471143030.cb0322s30","volume":"30","author":"C Thery","year":"2006","unstructured":"Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 30, 3\u201322 (2006).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"72834_CR24","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1161\/CIRCRESAHA.117.309417","volume":"120","author":"FAW Coumans","year":"2017","unstructured":"Coumans, F. A. W. et al. Methodological guidelines to study extracellular vesicles. Circ. Res. 120, 1632\u20131648 (2017).","journal-title":"Circ. Res."},{"key":"72834_CR25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.7150\/thno.18133","volume":"7","author":"P Li","year":"2017","unstructured":"Li, P., Kaslan, M., Lee, S. H., Yao, J. & Gao, Z. Progress in exosome isolation techniques. Theranostics 7, 789\u2013804 (2017).","journal-title":"Theranostics"},{"key":"72834_CR26","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1073\/pnas.1501321112","volume":"112","author":"F Mouliere","year":"2015","unstructured":"Mouliere, F. & Rosenfeld, N. Circulating tumor-derived DNA is shorter than somatic DNA in plasma. Proc. Natl. Acad. Sci. USA 112, 3178\u20133179 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72834_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","volume":"177","author":"DK Jeppesen","year":"2019","unstructured":"Jeppesen, D. K. et al. Reassessment of exosome composition. Cell 177, 428\u2013445 (2019).","journal-title":"Cell"},{"issue":"7","key":"72834_CR28","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41431-018-0132-4","volume":"26","author":"O P\u00f6s","year":"2018","unstructured":"P\u00f6s, O., Orsolya, B., Szemes, T. & Nagy, B. Circulating cell-free nucleic acids: characteristics and applications. Eur. J. Hum. Genet. 26(7), 937\u2013945 (2018).","journal-title":"Eur. J. Hum. Genet."},{"key":"72834_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-4939-7652-2_11","volume":"1740","author":"K Li","year":"2018","unstructured":"Li, K. et al. Isolation of plasma lipoproteins as a source of extracellular RNA. Methods Mol. Biol. 1740, 139\u2013153 (2018).","journal-title":"Methods Mol. Biol."},{"key":"72834_CR30","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.3892\/ol.2017.5889","volume":"13","author":"YX Hao","year":"2017","unstructured":"Hao, Y. X. et al. KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population. Oncol. Lett. 13, 3608\u20133616 (2017).","journal-title":"Oncol. Lett."},{"key":"72834_CR31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nm.3511","volume":"4","author":"AR Thierry","year":"2014","unstructured":"Thierry, A. R. et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat. Med. 4, 430\u2013435 (2014).","journal-title":"Nat. Med."},{"issue":"26","key":"72834_CR32","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1056\/NEJMp1512241","volume":"373","author":"H Singh","year":"2015","unstructured":"Singh, H. & Graber, M. L. Improving diagnosis in health care-the next imperative for patient safety. N. Engl. J. Med. 373(26), 2493\u20132495 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"72834_CR33","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/annonc\/mdz075","volume":"30","author":"JH Lee","year":"2019","unstructured":"Lee, J. H. et al. Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients. Ann. Oncol. 30(5), 815\u2013822 (2019).","journal-title":"Ann. Oncol."},{"key":"72834_CR34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.nano.2017.12.009","volume":"14","author":"J Klump","year":"2018","unstructured":"Klump, J. et al. Extracellular vesicles or free circulating DNA: where to search for BRAF and cKIT mutations?. Nanomedicine 14, 875\u2013882 (2018).","journal-title":"Nanomedicine"},{"key":"72834_CR35","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1158\/0008-5472.CAN-08-3860","volume":"69","author":"D Di Vizio","year":"2009","unstructured":"Di Vizio, D. et al. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res. 69, 5601\u20135609 (2009).","journal-title":"Cancer Res."},{"issue":"5","key":"72834_CR36","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1084\/jem.20181522","volume":"216","author":"H Garc\u00eda-Silva","year":"2019","unstructured":"Garc\u00eda-Silva, H. et al. Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF (V600E) mutation. J. Exp. Med. 216(5), 1061\u20131070 (2019).","journal-title":"J. Exp. Med."},{"key":"72834_CR37","first-page":"1","volume":"2020","author":"S Bernardi","year":"2020","unstructured":"Bernardi, S. et al. dsDNA from extracellular vesicles (EVs) in adult AML. Ann. Hematol. 2020, 1\u20132 (2020).","journal-title":"Ann. Hematol."},{"issue":"5","key":"72834_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/biomedicines8050131","volume":"8","author":"C Foroni","year":"2020","unstructured":"Foroni, C. et al. When less is more: specific capture and analysis of tumor exosomes in plasma increases the sensitivity of liquid biopsy for comprehensive detection of multiple androgen receptor phenotypes in advanced prostate cancer patients. Biomedicines 8(5), 131 (2020).","journal-title":"Biomedicines"},{"issue":"6","key":"72834_CR39","first-page":"2133","volume":"44","author":"S Bernardi","year":"2019","unstructured":"Bernardi, S. et al. Feasibility of tumor-derived exosome enrichment in the onco-hematology leukemic model of chronic myeloid leukemia. Int. J. Mol. Med. 44(6), 2133\u20132144 (2019).","journal-title":"Int. J. Mol. Med."},{"key":"72834_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000505088","volume":"9","author":"S Bernardi","year":"2020","unstructured":"Bernardi, S. et al. Exosomes in chronic myeloid leukemia: are we reading a new reliable message?. Acta Haematol. 9, 1\u20132 (2020).","journal-title":"Acta Haematol."},{"issue":"4","key":"72834_CR41","doi-asserted-by":"publisher","first-page":"e36084","DOI":"10.1371\/journal.pone.0036084","volume":"7","author":"L Morandi","year":"2012","unstructured":"Morandi, L. et al. Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation. PLoS ONE 7(4), e36084 (2012).","journal-title":"PLoS ONE"},{"key":"72834_CR42","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1373\/clinchem.2013.206375","volume":"59","author":"JF Huggett","year":"2013","unstructured":"Huggett, J. F. et al. The digital MIQE guidelines: minimum information for publication of quantitative digital PCR experiments. Clin. Chem. 59, 892\u2013902 (2013).","journal-title":"Clin. Chem."},{"key":"72834_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ymeth.2012.01.002","volume":"56","author":"BJ Tauro","year":"2012","unstructured":"Tauro, B. J. et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 56, 293\u2013304 (2012).","journal-title":"Methods"},{"key":"72834_CR44","doi-asserted-by":"publisher","first-page":"24858","DOI":"10.3402\/jev.v3.24858","volume":"3","author":"J Van Deun","year":"2014","unstructured":"Van Deun, J. et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J. Extracell Vesicles 3, 24858 (2014).","journal-title":"J. Extracell Vesicles"},{"key":"72834_CR45","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/jssc.200600394","volume":"30","author":"S Oh","year":"2007","unstructured":"Oh, S. et al. Miniaturized asymmetrical flow field-flow fractionation: application to biological vesicles. J. Sep. Sci. 30, 1082\u20131087 (2007).","journal-title":"J. Sep. Sci."},{"key":"72834_CR46","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.nano.2017.03.011","volume":"13","author":"EA Mol","year":"2017","unstructured":"Mol, E. A., Goumans, M. J., Doevendans, P. A., Sluijter, J. P. G. & Vader, P. Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation. Nanomedicine 13, 2061\u20132065 (2017).","journal-title":"Nanomedicine"},{"key":"72834_CR47","doi-asserted-by":"publisher","first-page":"e0170628","DOI":"10.1371\/journal.pone.0170628","volume":"12","author":"I Helwa","year":"2017","unstructured":"Helwa, I. et al. A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents. PLoS ONE 12, e0170628 (2017).","journal-title":"PLoS ONE"},{"key":"72834_CR48","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jim.2014.04.003","volume":"407","author":"Z Brownlee","year":"2014","unstructured":"Brownlee, Z., Lynn, K. D., Thorpe, P. E. & Schroit, A. J. A novel \u201csalting-out\u201d procedure for the isolation of tumor-derived exosomes. J. Immunol. Methods 407, 120\u2013126 (2014).","journal-title":"J. Immunol. Methods"},{"key":"72834_CR49","doi-asserted-by":"publisher","first-page":"e110443","DOI":"10.1371\/journal.pone.0110443","volume":"9","author":"A Ghosh","year":"2014","unstructured":"Ghosh, A. et al. Rapid isolation of extracellular vesicles from cell culture and biological fluids using a synthetic peptide with specific affinity for heat shock proteins. PLoS ONE 9, e110443 (2014).","journal-title":"PLoS ONE"},{"key":"72834_CR50","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.1038\/srep10266","volume":"5","author":"L Balaj","year":"2015","unstructured":"Balaj, L. et al. Heparin affinity purification of extracellular vesicles. Sci Rep. 5, 10266 (2015).","journal-title":"Sci Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72834-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72834-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72834-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:30:20Z","timestamp":1670355020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72834-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72834"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72834-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]},"assertion":[{"value":"16 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15745"}}